The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Biogen Inc(NASDAQ:BIIB) 
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to ...
Website: http://www.biogen.com
Founded: 1978
Full Time Employees: 7,400
Sector: Healthcare
Industry: Drug Manufacturers-General
Biogen Number of Twitter Followers
Biogen Days Payable Outstanding ttm (DPO)
Biogen Days Receivable Outstanding ttm (DSO)
Biogen Days Inventory Outstanding ttm (DIO)
Biogen Op Cashflow Per Share ttm
Biogen Free Cashflow Per Share ttm
Biogen Cash Per Share ttm
Biogen P/S ratio ttm
Biogen (GAAP) P/E ratio ttm
Biogen P/B ratio ttm
No extra charts and metrics for this ticker.